Evidence map›Paper›PMID 39052204›Full record

ArticleJournal of patient-reported outcomes2024

Translation, cross-cultural adaptation, and psychometric validation of the Malay version of the Assessment of Quality of Life-6 Dimensions (Malay-AQoL-6D) instrument among Malaysians living with chronic heart failure.

Yi Jing Tan, Siew Chin Ong, Sook Pin Goh, Gang Chen, Vee Sim Yong, Wei Wern Khor, Ying Min Kan, Yong Ying Choong, Ainul Mardhiyyah Zameram, Lin Yuing Tan and 5 more

Abstract readValidation Study
In one paragraph

Article in Journal of patient-reported outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yi Jing TanDiscipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Penang, 11800, Malaysia.
Siew Chin OngDiscipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Penang, 11800, Malaysia. siewchinong@usm.my.ORCID 0000-0002-9750-9588
Sook Pin GohDiscipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Penang, 11800, Malaysia.
Gang ChenCentre for Health Economics, Monash University, Caulfield East, VIC, 3145, Australia.
Vee Sim YongClinical Research Centre, Hospital Queen Elizabeth II, Institute for Clinical Research, National Institute of Health, Ministry of Health Malaysia, Kota Kinabalu, Sabah, 88300, Malaysia.
Wei Wern KhorSarawak General Hospital, Ministry of Health Malaysia, Kuching, Sarawak, 93586, Malaysia.
Ying Min KanSungai Dua Health Clinic, Ministry of Health Malaysia, Butterworth, Penang, 13800, Malaysia.
Yong Ying ChoongSeri Manjung Hospital, Ministry of Health Malaysia, Seri Manjung, Perak, 32040, Malaysia.
Ainul Mardhiyyah ZameramTengku Ampuan Afzan Hospital, Ministry of Health Malaysia, Kuantan, Pahang, 25100, Malaysia.
Lin Yuing TanTeluk Intan Hospital, Ministry of Health Malaysia, Teluk Intan, Perak, 36000, Malaysia.
James Yau Hon VooDuchess of Kent Hospital, Ministry of Health Malaysia, Sandakan, Sabah, 90000, Malaysia.
Kar Kei LamDuchess of Kent Hospital, Ministry of Health Malaysia, Sandakan, Sabah, 90000, Malaysia.
Chia How YenClinical Research Centre, Hospital Queen Elizabeth II, Institute for Clinical Research, National Institute of Health, Ministry of Health Malaysia, Kota Kinabalu, Sabah, 88300, Malaysia.
Mohamed Jahangir Abdul WahabPenang General Hospital, Ministry of Health Malaysia, Georgetown, Penang, 10990, Malaysia.
Zarina Banu AbdullaPenang General Hospital, Ministry of Health Malaysia, Georgetown, Penang, 10990, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to translate and culturally adapt the Assessment of Quality of Life (AQoL)-6D into Malay (Malay-AQoL-6D), and assesses the instrument's acceptability, reliability, and validity among Malaysians living with chronic heart failure (HF).

methodsThe translation and cross-cultural adaptation process adhered to international guidelines. The Malay-AQoL-6D underwent content and face validity assessments via expert review, and pretesting among healthy individuals and patients with chronic conditions. Subsequent psychometric validation utilised clinico-sociodemographic data and paired AQoL-6D and EQ-5D-5L data from a health-related quality-of-life (HRQoL) survey involving Malay-speaking patients with HF, which encompassed assessments of Malay-AQoL-6D acceptability, internal consistency and test-retest reliability, as well as its construct, concurrent, convergent and divergent, and known-group validity.

resultsThe Malay-AQoL-6D was deemed acceptable among clinicians and local patients, achieving a 90.8% completion rate among 314 patients surveyed. The instrument demonstrated strong content validity (item-level content validity index [CVI]: 0.83-1.00, average CVI: 0.98), internal consistency (Cronbach's alpha: 0.72-0.89; MacDonald's omega: 0.82-0.90, excluding the Senses dimension), and test-retest reliability (average intraclass correlation coefficients: 0.79-0.95). Confirmatory factor analysis confirmed the instrument's two-level, six-factor structure (Satorra-Bentler [SB]-scaled χ2(df: 164): 283.67, p-value < 0.001; root mean square error of approximation [RMSEA]: 0.051; comparative fix index [CFI]: 0.945, Tucker-Lewis index [TLI]: 0.937; standardised root mean-squared error [SRMR]: 0.058). The Malay-AQoL-6D's concurrent validity was evident through its good agreement with EQ-5D-5L. Multiple hypothesis tests further affirmed its construct and known-group validity. The Malay-AQoL-6D's psychometric properties remained consistent across different missing data techniques.

conclusionThe findings suggest that Malay-AQoL-6D could be a culturally acceptable, reliable, and valid HRQoL measure for quantifying HRQoL among the local HF population. Future studies are necessary to further validate the instrument against other measures and confirm the instrument's test-retest reliability and responsiveness, which are possible with the availability of the Malay-AQoL-6D.

Indexed as

Cross-Cultural ComparisonHeart FailurePsychometricsQuality of LifeAdultAgedChronic DiseaseFemaleHumansMalaysiaMaleMiddle AgedReproducibility of ResultsSoutheast Asian PeopleSurveys and QuestionnairesTranslationsAQoL-6DConfirmatory factor analysisEQ-5D-5LHealth-related quality of lifeHeart failureMalayPsychometric validationReliabilityTranslation and cross-cultural adaptationValidity

Identifiers

PMID39052204
PMCPMC11272755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.